by Osel | Oct 10, 2016 | announcements
Osel Featured in Chemistry & Industry Magazine Osel was featured in the September issue of Chemistry & Industry Magazine, a publication of the UK Society of Chemical Industry (SCI), for an article focusing on the role of the healthy vaginal microbiome in...
by Osel | Jul 21, 2016 | announcements
Osel, Inc. Comments on New Study Showing Role of Vaginal Microbiome in Women’s Health Osel’s Live Biotherapeutic Approach Aims to Restore Healthy Microbial Balance in Women Affected by Vaginal Dysbiosis Company Currently Conducting Phase 2b Clinical Trial of Lead...
by Osel | May 16, 2016 | announcements
Osel, Inc.’s Lead Product LACTIN-V Enters Phase 2b Study to Prevent Recurrence of Bacterial Vaginosis Mountain View, CA (May 11, 2016): Osel, Inc. today announced the initiation of a Phase 2b clinical study of its lead product candidate, LACTIN-V, to prevent the...
by Osel | May 16, 2016 | announcements
Osel highlighted in BioCentury’s cover story “Community organizers” BioCentury Reports on Efforts to Alter the Microbiome for Improved Health Osel is featured in an informative new article published in BioCentury titled “Community Organizers.” The...
by Osel | May 16, 2016 | announcements
Osel Inc. Noted as a “A Company to Watch” by Life Science Leader We were proud to be featured in the April 2016 issue of Life Science Leader as a “Company to Watch.” READ THE...
